Transcript Slide 1

AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
Case Study
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
AUGMENTED REALITY
CASE STUDY
 Exposure treatment: One hour.
 The patient interacted with the
cockroach in the container, and also with
the cockroach outside the container.
 The patient killed four cockraches.
AUGMENTED REALITY
 Treatment outcomes were maintained
at one-month follow-up.
 Reports of high Reality judgment and
Presence.
AUGMENTED REALITY
Case Series Study
Participants: 10 patients so far (9 women and 1
man)
 Four with spider phobia
 Six with cockroach phobia
Treatment: Adaptation of the one-session exposure
program developed by Öst delivered with
Augmented Reality.
AUGMENTED REALITY
Results: BAT (0-12)
PATIENTS
1
2
3
4
5
6
7
8
9
10
BASELINE
5
6
6
7
5
0
0
5
0
5
PRE-TEST
5
6
6
7
5
0
0
5
0
5
POST-TEST
12
12
12
12
12
12
12
12
12
12
AUGMENTED REALITY
Results: Self-report (0-126)
PATIENTS
1
2
3
4
5
6
7
8
9
10
PRE-TEST
114
91
95
60
111
95
95
71
95
121
POST-TEST
19
68
40
35
86
45
48
34
39
43
AUGMENTED REALITY
Preference: IN VIVO vs AR (0-7)
PATIENTS
1
2
3
4
5
6
7
8
9
10
Willingness of getting
involved in a treatment
with AR exposure
7
4
7
7
7
7
6
7
7
7
Willingness of getting
involved in a treatment
with in vivo exposure
6
4
4
5
4
2
4
4
5
5
AUGMENTED REALITY
Satisfaction (0-10)
PATIENTS
1
2
3
Do you think the
procedure is logic?
9
9
10 10 10 10 10 10 10
10
Your level of satisfaction
with the procedure
10 9
9
8
8
8
10 10 10
10
Would you recommended
it to a friend?
10 9
10 9
9
10 10 10 10
10
Do you think it could be
useful for treating other
psychological problems?
10 9
10 10 8
10 10 10 10
10
Do you find the treatment
aversive?
2
7
0
7
Do you think the treatment 10 7
has been useful in treating
your problem?
4
5
6
7
8
9
1
5
7
1
7
9
10 7
7
7
9
10 10
10
10
AUGMENTED REALITY
Conclusions
 AR:
Efficacious in the treatment of specific
phobia.
 Significant reduction in objective and
subjective measures of fear and avoidance.
 Patients preferred AR rather than in vivo
exposure.
 Patients were satisfied with the treatment.
Controlled Studies: n > 8
Fear of Driving
Author
Berger
Country Year
# of Pts
Tx Grps
U.S.
1999
16
PC VR, Phobics, Non-Phobics
Korea
1999
9
PC VR, WLC
U.S.
2001
9
VR, In vivo
Jang
Korea
2002
11
Driving vs. Flying
Walshe
Ireland
2003
14
ECT, CBT, WLC
Kim
Wiederhold
 Types of VR equipment used clinically:
Multiple Screens
Regular Desktop
Head Mounted
Display
Full Car
Automobile Seat
Driving Study: 9 participants
(Wiederhold BK, Jang DP, Kim SI, Wiederhold MD, 2001)
12%
Treatment Success
Based on Framework Type
100%
80%
88%
Specific Phobia
PDA
PTSD
60%
Success
40%
20%
0%
Type 1
Type 2
Type 3
Type 4
Fear of Driving Movie Clip
Social Phobia
Patient wearing a HMD while engaging in the virtual party
Controlled Studies: n > 8
Social Phobia
Author
Country
Year
# of Pts
Slater
Lègeron
Roy
Klinger
U.K.
France
France
France
2003
2003
2003
2005
10
36
10
36
Tx Grps
Neutral, demanding
VR, CBT
VR, CBT, WLC
VR, CBT
Social Phobia
(Klinger, Bouchard et al., 2004)
Liebowitz (total)
Hamilton Anxiety
100
12
80
10
8
60
6
40
4
20
2
0
0
Pre
Post
in VR
CBT
0
-5
-10
-15
-20
-25
-30
Post
in VR
Post
in VR
Rathus (assertiveness)
Pre
Pre
CBT
N = 36, 12 sessions. CBT in group.
CBT
SOCIAL PHOBIA
(Klinger et al., 2005)
• Sample Population = 18 participants
– 10 females and 8 males
– Mean age: 30.5 ± 5.06
– On average, participants have been suffering from
social phobia for 14.5 years
– 9 participants were also displayed symptoms of
major depression
(all information based only on the VRT group)
SOCIAL PHOBIA
(Klinger et al., 2005)
• Measures
– The Short Beck Depression Inventory (BDI-13)
– The Liebowitz Social Anxiety Scale (LSAS)
– The Rathus Assertiveness Schedule
– The Zigmond and Snaith Hospital Anxiety
Depression Scale (HAD)
SOCIAL PHOBIA
(Klinger et al., 2005)
• Protocol – for VRT only
– Overview
• 12 sessions of VRT
• 45 minutes each
• Exposed to virtual environments for either assessment
or therapy
• Virtual exposure lasts less than 20 minutes per session
SOCIAL PHOBIA
(Klinger et al., 2005)
• Protocol (cont’d)
– Virtual environments included 4 situations that
social phobic patients felt were the most
threatening:
•
•
•
•
Performance
Intimacy
Scrutiny
Assertiveness
SOCIAL PHOBIA
(Klinger et al., 2005)
• Protocol (cont’d)
– Session 1
• Therapist presents virtual world to patient
• Patient familiarizes the virtual world and tools in a
neutral environment
– Session 2-9
• 2 sessions devoted to each of the 4 virtual
environments
– Assessment, expose patient to VR environment, 2 phases of
“therapy” exposure to the environment
SOCIAL PHOBIA
(Klinger et al., 2005)
• Protocol (cont’d)
– Session 10-12
• 3 sessions devoted to more focused and detailed work
on one or two of the four environments that gave the
patient the most trouble
• 12th session = conclusion to therapy and introduction of
a personal program to carry out beyond the therapy
SOCIAL PHOBIA
(Klinger et al., 2005)
SOCIAL PHOBIA
(Klinger et al., 2005)
• Conclusion:
– Based on the LSAS, VRT would illustrate a better form of
treatment over CBT
– The differences between the two groups, however, are not
significant
– For VRT to be significantly better than CBT in terms of social
phobia symptoms, experiment participants would have to be
increased to 200-300
– Participants should be increased to a sample of 3,000 in order to
find a significant difference in performance anxiety
– In order to further confirm the efficacy of virtual reality for the
treatment of social phobia, additional outcome studies could be
conducted with the inclusion of a third control condition such as a
placebo or a waiting list
Social Phobia Movie Clip
Internet-based Worlds
SOCIAL PHOBIA
Online Worlds to Help with Social Phobia
www.there.com
www.secondlife.com
Human Avatars
Animal Avatars
Controlled Studies: n > 8
Panic Disorder with Agoraphobia
Author
Country Year # of Pts
North
U.S.
1998
30
Kim
Korea 1999
9
Botella
Spain 2002
10
Wiederhold
U.S.
2002
9
Botella
Spain 2003
36
Tx Grps
PC VR, WLC
PC VR, WLC
PC VR, In vivo
Non-phobics in PDA environ.
VRE, In vivo, WLC
Multi-center Controlled Study
Riva
Wiederhold
Bouchard
Kim
Italy
U.S.
Canada
Korea
2002
2002
2002
2002
45
45
45
45
PC VR, In vivo, WLC
PC VR, In vivo, WLC
PC VR, In vivo, WLC
PC VR, In vivo, WLC
Agoraphobia: 12 participants
(Vincelli, Anolli, Bouchard, Wiederhold, Zurloni, & Riva, 2003)
Patient Treatment



VR-CBT
CBT
WLC
Design


VR-CBT 8 sessions
CBT 12 sessions
Results

VR-CBT produced same or
better results using 33%
fewer sessions than CBT
Measures




Beck Depression
Inventory
State Trait Anxiety
Inventory
Agoraphobic Cognitions
Questionnaire
Fear Questionnaire
Agoraphobia: 12 participants
(Vincelli, Anolli, Bouchard, Wiederhold, Zurloni, & Riva, 2003)
Fear Questionnaire
Panic attack frequency
60
1.5
50
40
1
30
0.5
20
10
0
Pre Rx
0
Post Rx
CBT-VR
Pre Rx
CBT
Post Rx
CBT-VR
BDI-II
25
20
15
10
5
0
Pre Rx
Post Rx
CBT-VR
CBT
CBT
“The Mall”
“The Room”